-
Ten considerations for integrating patient-reported outcomes into clinical care for childhood cancer survivors
2023
Citation: 15(4):1024
Author(s): Horan MR, Sim JA, Krull KR, Ness KK, Yasui Y, Robison LL, Hudson MM, Baker JN, Huang IC
Journal: Cancers (Basel)
-
Genetic variants, neurocognitive outcomes, and functional neuroimaging in survivors of of childhood acute lymphoblastic leukemia
2023
Citation: 7(4):pkad039
Author(s): Gandy K, Sapkota Y, Scoggins MA, Jacola LM, Koscik TR, Hudson MM, Pui CH, Krull KR, van der Plas E
Journal: JNCI Cancer Spectr
-
Subsequent female breast cancer risk associated with anthracycline chemotherapy for childhood cancer
2023
Citation: 29(9):2268-2277
Author(s): Wang Y, Ronckers CM, van Leeuwen FE, Moskowitz CS, Leisenring W, Armstrong GT, de Vathaire F, Hudson MM, Kuehni CE, Arnold MA, Demoor-Goldschmidt C, Green DM, Henderson TO, Howell RM, Ehrhardt MJ, Neglia JP, Oeffinger KC, van der Pal HJH, Robison LL, Schaapveld M, Turcotte LM, Waespe N, Kremer LCM, Teepen JC
Journal: Nat Med
-
Interventions with social integration components addressing psychosocial outcomes of young- and middle-aged adult cancer individuals: A systematic review
2023
Citation: 15(19):4710
Author(s): Poudel PG, Horan MR, Brinkman TM, Wang Z, Robison LL, Hudson MM, Huang IC
Journal: Cancers (Basel)
-
Polygenic risk and chemotherapy-related subsequent malignancies in childhood cancer: A Childhood Cancer Survivor Study and St. Jude Lifetime Cohort Study report
2023
Citation: 41(27):4381-4439
Author(s): Im C, Sharafeldin N, Yuan Y, Wang Z, Sapkota Y, Lu Z, Spector LG, Howell RM, Arnold MA, Hudson MM, Ness KK, Robison LL, Bhatia S, Armstrong GT, Neglia JP, Yasui Y, Turcotte LM
Journal: J Clin Oncol